Tomer Kariv - Profile and Investment Details

Investor Profile

Tomer Kariv is a Venture Capital, Founder, Private Equity Firm, CEO, Investor based in Tel Aviv District, Israel with a diverse investment portfolio that includes companies such as Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb, Otic PharmaVico Therapeutics, Eloxx, Silverback Therapeutics, Arno Therapeutics, ArQule, Prevail Therapeutics, Precirix, ARTSaVIT, Nutrinia, Stimatix GI, Stargazer Pharmaceuticals, Adicet Bio, Ocon Healthcare, Abcuro, Horama, Sweetch, StrideBio, Aposense, TargEDys, Neogene Therapeutics, Entera Bio, Raziel Health, Avraham Pharmaceuticals, EyeYon, Step Pharma, Check-Cap, HeadSense Medical, ABAC Therapeutics, Applied Immune Technologies, Metabomed, LogicBio Therapeutics, CritiSense, Collplant, Keros Therapeutics, Eyevensys, Alizé Pharma, MacroCure, cCAM Biotherapeutics, Fore Biotherapeutics, UroGen Pharma, Tisbury Pharmaceuticals, V-Wave, 89bio, Mereo Biopharma, Dynacure, AgomAb Therapeutics, Pi Therapeutics, . Over time, Tomer Kariv has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Tomer Kariv is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Wellness, Immunotherapy, Rare Diseases, Telemedicine, Life Science, Portfolio Management, Medical Technologies, Startups, Information Technology (IT), Manufacturing, Biotechnology, Medical Devices, Drug Development, Entrepreneurship, Electronic Health Records (EHR), Health and Hospital Services, Innovation, Clinical Trials, Gene Therapy, Personalized Medicine, Digital Health, Travel, Medical, Information Technology, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Tomer Kariv, as their portfolio suggests a familiarity and interest in this area.

Understanding Tomer Kariv’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.